MS Contin treatment of severe pain in advanced cancer of 65 cases.doc

 PAGE \* MERGEFORMAT 6 MS Contin treatment of severe pain in advanced cancer of 65 cases [Keywords:] MS Contin severe pain with advanced cancer So far, cancer is still human not a major problem to overcome. Recent data show that the United States in 2007 there will be 1,444,920 new cancer patients and 559 650 people die of cancer. Since 1999, in the younger than 85-year-old population, cancer has replaced heart disease as the highest mortality in children aged 1 to 14, also following the accident to the second row. No doubt, the number of incidence and deaths will be more. cancer pain as an important symptom of a serious impact on patients with advanced cancer pain, quality of life, the application MS Contin (MST (morphine sulfate controlled-release tablets, Beijing Pharmaceutical Co Meng Di severe pain in patients with advanced cancer achieved good results in 65 cases are summarized as follows. Materials and Methods 1. General Information 65 patients in this group, 38 males and 27 females, aged 33 to 87 years, mean 66.2 years, of which 25 cases of lung cancer, other cancers, including colon cancer, 13 cases of gastric cancer in 11 cases, 7 cases of liver cancer, pancreatic cancer 4 cases, 3 cases of breast cancer, unexplained bone metastasis in 2 cases. All cases were pathologically diagnosed as advanced cancer, there are different parts of distant metastasis, grade pain (severe pain, treatment observation for two weeks, during which no deaths . 2. Treatment The initial therapeutic dose of 30 mg, orally once every 12 h was observed 2 to 3 days, such as pain relief is not obvious, at 30% to 50% dose increments until pain relief. The group maximum dose 90 mg/12 h. observed during the treatment of cancer pain and side effects, and to appropriate symptomatic treatment. 3. ABLATION Pain: the pain complained of by WHO classification scheme (VRS Rating: 0, no pain, level, mild pain, although pain can still work, sleep interference, grade